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Colorectal cancer (CRC) is the third most common cancer III Malaysia and is
currently the commonest cancer in males. Genetics, experimental and
epidemiological data suggest that CRC develops from complex interaction between
inherited susceptibility and environmental factors. Accumulating evidence suggests
that the Wnt and PI3K (phosphoinositide-3-kinase)/Akt signalling pathways playa
causative role in tumorigenesis of colorectal cancer.
By employing immunohistochemical method, the expressIOn and correlation of
several key regulators or related biomolecules of the Wnt and PI3K1Akt signalling
pathways in 47 archival formalin fixed, paraffin embedded tissues of surgically
resected colorectal cancer (CRC) specimens performed at Kuala Lumpur Hospital
(KLH) between 1999 and 2000, were studied. Laser captured microdissection
iii
technique, polymerase chain reaction and direct sequencing were used to investigate
mutations in exon 3 of the p-catenin gene. Mutations in the mutation cluster region
(MCR) of adenomatous polyposis coli (APC) gene were also investigated. The
expressions of Wnt-l, WISP-l and FRAT-l mRNA were determined by
reverse-transcription and real-time polymerase chain reaction method.
The results showed that: The expressions ofWnt-l, FRAT-I, APC, nuclear p-catenin,
cytoplasmic p-catenin, membrane p-catenin, membrane E-cadherin, cytoplasmic
E-cadherin, WISP-I, cyclin-Dl, p-Aktl (Ser473), p-Akt1l2/3 (Thr308), p-BAD
(Ser136), p-GSK 3p(Ser9) and survivin were found in 55.3%, 36.2%, 51.1% 44.6%,
95.7%,30.6%,46.8%,95.7%,31.9%, 10.6%,34%,44.7%,57.4% 44.7% and 59.6%
of CRC tissues, respectively and 17.5%, 5% 100%, 0%, 75%, 100%, 100%, 50%,
12.5%, 0%, 5%, 12.5%, 22.5%, 22.5% and 32.5% of apparently normal adjacent
tissues, respectively. The sum of scores for all biomolecules except APC, membrane
p-catenin and membrane E-cadherin staining was significantly higher in CRC tissues
in comparison to apparently normal adjacent tissues (p < 0.05). The sum of score for
APC, membrane p-catenin and membrane E-cadherin staining was significantly
lower in CRC tissues in comparison to apparently normal adjacent tissues (p < 0.05).
The expression of Wnt and PI3K1Akt signalling pathway-related biomolecules was
interrelated. The results ofnucleotide sequencing showed that no mutations at exon-3
of p-catenin were found. However, point mutations in the mutation cluster region of
the APC gene leading to the formation of truncated APC protein, were found in four
iv
out eleven CRC tissues examined. A 1.43 to 21.26-foid and 1.11 to 109.14-fold
increase in the level of expression of Wnt-l and FRAT-1 mRNA was found in eight
out of eleven CRC tissues relative to apparently normal adjacent tissues. On the other
hand, a 1.94 to 46.69-fold increase in the level of WISP-I mRNA was found in all
the CRC tissues.
This study has provided important information for researchers and clinicians in terms
of clinical evidence of the involvement of the Wnt signalling pathway and PI3K1Akt
signalling pathway in colorectal tumorigenesis. In addition, the present study also
provided crucial information on the elucidation of the relationship between the
biomolecules of these signalling pathways towards understanding their roles in
colorectal tumourigenesis and the identification of potential targets for advance
therapeutic intervention ofCRe. Based on our current results, we propose that Wnt-I,
FRAT-1 and WISP-I could be served as potent therapeutic target for the treatment of
CRe.
On the basis of our present study, we conclude that the Wnt and PI3K1Akt signalling
pathways are involved in tumourigenesis of CRC in Malaysia. These pathways are
interrelated although they might also act independently in promoting tumour growth
and inhibition of apoptosis. This study has also provided useful information for the
search or design of better antitumour interventions.
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Barah kolorektal (CRC) merupakan barah yang ketiga paling kerap di Malaysia dan
pada ketika ini, ia merupakan barah yang paling kerap di kalangan lelaki. Data
genetik, eksperimental dan data epidemiologi menyarankan bahawa CRC
berkembang hasil interaksi antara faktor persekitaran dan faktor keturunan.
Bukti-bukti telah menyarankan bahawa lintasan isyarat PI3K
(phosphoinositide-3-kinase) /Akt dan Wnt memainkan peranan yang penting dalam
perkembangan barah kolorektal.
Dengan menggunakan kaedah immunohistokimia, ekspresi dan hubungan antara
beberapa pengawal-atur atau biomolekul yang berkaitan dengan lintasan isyarat
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PI3KJAkt dan Wnt telah dikaji dalam 47 sampel tisu yang diperolehi daripada
pesakit CRC yang menjalani pembedahan di Hospital Kuala Lumpur antara 1999 dan
2000 dan telah diblokkan di dalam paraffin. Kaedah "laser captured microdissection",
" polymerase chain reaction (PCR)" dan "direct-sequencing" telah digunakan untuk
mengkaji mutasi yang berlaku pada ekson 3, ge"n 13-katenin. Mutasi pada "mutation
cluster region (MCR)", gen APC juga dikaji. Ekspresi mRNA Wnt-l, WISP-l dan
FRAT-l juga dikenalpasti dengan menggunakan kaedah "real-time"-PCR.
Keputusan kami menunjukkan bahawa ekspresi Wnt-l, FRAT-1, APC, 13-katenin
nukleus, 13-katenin sitoplasma, 13-katenin membran, E-cadherin membran, E-cadherin
sitoplasma, WISP-I, cyclin-Dl, p-Aktl (Ser473), p-Aktl/2/3 (Thr308), p-BAD
(Ser136), p-GSK 313(Ser9) dan survivin telah dikesan di 55.3%, 36.2%, 51.1 % 44.6%,
95.7%,30.6%,46.8%,95.7%,31.9%,10.6%,34%,44.7%, 57.4% 44.7% dan 59.6%
tisu CRC, masing-masing dan 17.5%, 5% 100%, 0%, 75%, 100%, 100%, 50%,
12.5%, 0%, 5%, 12.5%, 22.5%, 22.5% dan 32.5% tisu sekeliling yang kelihatan
biasa, masing-masing. Jumlah skor untuk semua biomolekul kecuali APC, 13-katenin
membran and E-cadherin membran adalah lebih tinggi dalam tisu CRC berbanding
dengan tisu sekeliling yang kelihatan biasa (p < 0.05). Jumlah skor untuk APC,
13-katenin membran and E-cadherin membran adalah lebih rendah dalam tisu CRC
berbanding tisu sekeliling yang kelihatan biasa (p < 0.05). Ekspresi biomolekul yang
berkaitan dengan lintasan isyarat Wnt dan PI3KJAkt adalah saling berhubungan.
Keputusan penjujukan menunjukkan bahawa tidak ada mutasi berlaku di ekson-3,
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gen p-katenin. Walau bagaimanapun, mutasi pada MCR, gen APC yang
menyebabkan pembentukan protein APC yang "truncated" telah dikesan pada empat
daripada sebelas spesimen CRC yang dikaji. Peningkatan ekspresi mRNA Wnt-l dan
FRAT-1 sebanyak 1.43 ke 21.26-kali dan 1.11 ke 109.14-kali masing-masing telah
didapati dalam lapan daripada sebelas tisu CRC berbanding tisu sekeliling yang
kelihatan biasa. Sebaliknya, peningkatan sebanyak 1.94 ke 46.69-kali mRNA
WISP-l telah beIjaya dikesan di kesemua tisu CRC yang dikaji.
Kajian ini telah menghasilkan maklumat yang penting kepada para penyelidik dan
perubatan dari segi bukti klinikal bagi pembabitan lintasan isyarat Wnt dan PI3K1Akt
dalam tumorigenesis kolorektal. Kajian kami juga memberi maklumat penting dalarn
penjelasan hubungan antara biomolekul bagi lintasan isyarat yang berkenaan, menuju
pemahaman peranan mereka di dalarn tumorigenesis kolorektal dan pengenalan
sasaran-potensi bagi intenvensi CRC therapi maju. Berdasarkan keputusan ini, karni
mencadangkan bahawa Wnt-l, FRAT-l dan WISP-l boleh dianggap sebagai sasaran
teraputik yang berpotensi untuk rawatan CRe.
Berdasarkan keputusan yang diperolehi, kami membuat kesimpulan bahawa lintasan
isyarat Wnt dan PI3K1Akt adalah berkait dengan tumourigenesis CRC di Malaysia.
Lintasan isyarat ini adalah saling berhubungan walaupun mereka juga boleh
bertindak secara bersendirian untuk menggalakkan pertumbuhan barah dan
perencatan apoptosis. Kajian ini telah memberi maklumat yang berguna kepada para
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penyelidik dan doctor perubatan dalam penemuan dan penerokaan intervensi
anti-barah yang lebih baik.
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